Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard B. Slansky currently holds 270,016 shares of GenMark Diagnostics, Inc. (GNMK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard B. Slansky has been a net buyer of GNMK stock. They have purchased $1.0M and sold $178.2K worth of shares.
Richard B. Slansky's most recent insider trade was on Jul 5, 2018, when they sold 6,725 shares at $1.31 per share.
Richard B. Slansky serves as Executive at GenMark Diagnostics, Inc. (GNMK). They have executed 46 insider transactions totaling $1.2M over their tenure at the company.
Richard B. Slansky holds the position of Executive at GenMark Diagnostics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Richard B. Slansky has shown a buying trading pattern, with $1.0M in total purchases and $178.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Richard B. Slansky was on Jul 6, 2015, when they purchased $918.0K worth of ONCS shares. This transaction involved 150,000 shares at $6.12 per share.
Richard B. Slansky currently owns 270,016 shares of GenMark Diagnostics, Inc. (GNMK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard B. Slansky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard B. Slansky has 46 Form 4 filings on record as an insider at GenMark Diagnostics, Inc..
Set alerts for Richard B. Slansky and 40,000+ other insiders.